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Recent studies on the dynamics of human immunodeficiency plausible that the emergence of SI variants will coincide with an increase in serum HIV-1 RNA. However, to our knowledge, virus (HIV)-1 infection showed a continuously high rate of viral replication linked to CD4 T cell depletion [1, 2] . One of frequent serial testing of HIV-1 RNA level around viral phenotype conversion has not been done. Two cross-sectional studies the potential mechanisms of CD4 T cell depletion is HIVmediated formation of syncytia. Syncytium-inducing (SI) varifound no significant difference between RNA level in persons with virus with the non -syncytium-inducing (NSI) phenotype ants generally only emerge during the course of HIV infection, and their presence is associated with accelerated CD4 T cell and the SI phenotype [9, 10] . With respect to cellular virus load, two studies reported that the proportion of infected CD4 decline and faster progression to AIDS [3, 4] . In a previous study, we found that after adjusting for CD4 T cell count as a T cells increased with the emergence of SI variants [4, 11] .
To improve the understanding of the relationship between time-dependent covariate, SI phenotype remained a marker for progression to AIDS [5] . These results indicate that the detecbiologic phenotype, RNA load, and CD4 T cell count, we evaluated the dynamics of RNA level and CD4 T cell count tion of SI phenotype adds important and distinct prognostic information to CD4 T cell count measurements. Only recently, around NSI-to-SI phenotype conversion in sequential serum samples of 123 HIV-infected persons with documented interval quantification of HIV-1 burden became commercially available. Serum or plasma HIV-1 RNA level was found to be a of seroconversion. In addition, we studied whether SI phenotype remained an independent marker for progression to AIDS strong predictor for disease progression [6, 7] . Because SI variants have a broader T cell host range [8] , it is biologically after adjusting for RNA level and CD4 T cell count. were examined every 3 months, and blood samples were obtained.
Methods
HIV-1 RNA level was determined in stored (070ЊC) serum matched). If more than one measurement per person was available within one time period, only one measurement (closest to samples at seroconversion (defined as the first seropositive sample), at 3 and 6 months thereafter, and subsequently at 1-year the midpoint of the time period) was taken into account for the median value. If õ10 subjects with a measurement were intervals until the end of follow-up in the cohort study. In the 123 homosexual men, 1794 RNA measurements were made (median, available within a specific time period, this time period was omitted. Differences between groups at each time point were 14/subject; range, 2-45; interquartile range [IQR], [10] [11] [12] [13] [14] [15] [16] [17] [18] . Viral phenotype and CD4 cell count were measured every visit.
tested with the Mann-Whitney U test (P õ .05 was considered statistically significant). Differences in median RNA level beFifty-four of the 123 men progressed to AIDS after a median of 4.6 years (range, 0.5-10.3) after seroconversion, and 69 did tween two time points before and after phenotype conversion were tested by Wilcoxon matched-pairs signed-ranks test. Adnot develop AIDS (median follow-up, 6.0 years; range, 0.1-10.9). Among those men developing AIDS, 47 died after a median folditional analyses were done: excluding RNA measurements at time points with CD4 cell counts õ100, studying a subpopulalow-up of 6.9 years (range, 0.8-10.3) from seroconversion. Of the 123 men, 73 (59%) seroconverted between 1985 and 1987 and 50 tion of participants who were followed for ú3 years after the switch, and excluding RNA measurements from the start of (41%) between 1988 and the end of 1995. Treatment with three antiretroviral drugs was used by 1 subject at the last visit of the antiretroviral treatment. Also, median RNA levels during time since seroconversion were study, while 25 and 23 subjects were treated with two and one antiretroviral drug(s), respectively, for various time periods.
calculated for those who remained NSI for ú9 years after seroconversion (n Å 12) and those who converted from NSI to SI Laboratory methods. Sera were screened for the presence of antibodies to HIV-1 with a commercial EIA (Abbott Laboratories, phenotype at some time point during follow-up (n Å 39). Median RNA levels for the latter group were divided into the NSI course Abbott Park, IL) and confirmed by Western blot (Genelabs, Herent, Belgium). and the SI course and shown as two curves. Kaplan-Meier survival analysis and Cox proportional hazards HIV-1 RNA was quantified by using a nucleic acid sequencebased amplification assay (NASBA HIV-1 RNA QT; Organon analysis were used to study the cumulative incidence of viral phenotype conversion and AIDS and the predictive value of RNA Teknika, Boxtel, The Netherlands) according to the instructions of the manufacturer. The threshold of quantification, with 100 mL levels, SI phenotype, and CD4 T cell counts for these outcomes.
In the Cox analysis, both uni-and multivariate models were fitted, of serum, was 10 3 RNA copies/mL. RNA levels were determined in batch purely randomly, thus, without selection by viral phenotype.
treating the markers as time-dependent covariates. AIDS-free subjects were censored at 1 year after the last visit with RNA determiLymphocyte immunophenotyping for peripheral CD4 and CD8 T cells was done by flow cytometry using dual-color immunofluonation, at death, or on 1 January 1996. Categories of CD4 T cell count (ú500, 300-500, õ300 cells 1 10 6 /L) were defined by the rescence.
To determine HIV-1 phenotype, HIV-1 was isolated from fresh 33rd and 67th percentile and of RNA level by the 25th, 50th, and 75th percentile (õ10 , ú10 4.9 copies/ or cryopreserved peripheral blood mononuclear cells by cocultivation with MT-2 lymphoblastoid cells (Medical Research CouncilmL). In the time-dependent analysis, the two lowest quartiles of RNA level were combined because no AIDS occurred in the lowest AIDS Reagent Project, Potters Bar, UK). Isolates producing syncytia in MT-2 cells were considered SI (NSI isolates do not replicate quartile. The 3 subjects with SI phenotype at seroconversion were excluded in the analysis concerning the cumulative incidence of in MT-2 cells).
Statistical analysis. The moment of phenotype conversion was SI phenotype. estimated as the midpoint between the date of the last NSI phenotype visit and the first SI phenotype visit. For RNA copy numbers Results below the test threshold of quantification, the amount of RNA was arbitrarily set at 10 2.9 or 999 RNA copies/mL. years (range, 0.4 -9.2).
Dynamics of HIV-1 RNA level around viral phenotype con-
controls) were studied, because 8 subjects were excluded for
The first detection of SI variants occurred at all levels of various reasons (3 subjects in whom SI variants were detected RNA; of the 26 subjects who showed a phenotype conversion from seroconversion onwards, 2 subjects who showed phenoand who had an RNA determination available within 6 months type conversion within 1 year from HIV-1 seroconversion, 1 before conversion, 6 subjects (23%) had RNA levels ú4.9 log subject who had no CD4 T cell counts around 1 year before the phenotype conversion, and 2 subjects who could not be copies/mL, 5 (19%) between 4.5 and 4.9 log copies/mL, 11
/ 9d4c$$au17 06-29-98 13:01:48 jinfas UC: J Infect (42%) between 3.0 and 4.5 log copies/mL, and only 1 (4%) At the individual level, the amount of viral RNA around phenotype conversion varied greatly, but the majority showed below the quantification limit of 3.0 log copies/mL. Also, CD4 T cell count at the first detection of SI variants varied greatly; the pattern of an increase around conversion and a subsequent decrease. All 39 individual curves showed an increase in RNA of the 39 subjects who showed a phenotype conversion and who had a CD4 T cell count available within 6 months before level around phenotype conversion, varying from 5000 to 1,300,000 RNA copies/mL (median, 100,000) or from 0.1 to switch, 6 subjects (15%) had CD4 T cell counts õ300 1 10 6 / L, 13 (33%) between 300 and 500 1 10 6 /L, and 20 (51%) 2.0 log copies/mL (median, 0.7), which started between 1 year before and 1 year after the estimated conversion in 34 (87%) ú500 1 10 6 /L. The dynamics of RNA level and CD4 T cell count from 3 subjects and ú1 year after the conversion in 5 (13%) subjects. A consequent decrease was observed in 33 (85%) of those who years before till 4 years after the NSI-to-SI conversion is shown in figure 1 for 34 patients and 34 matched controls converted, varying from 5000 to 1,000,000 RNA copies/mL (median, 65,000) or from 0.1 to 1.5 log copies/mL (median, who did not show a viral phenotype conversion. Median RNA levels before the NSI-to-SI conversion were characterized by 0.4), which started between 6 months and 2 years after the conversion in 22 (56%) subjects and ú2 years after the switch relatively stable values of Ç30,000 copies/mL (3 months before conversion IQR, 13,750 -92,000) or 4.5 log copies/ in 11 (28%) subjects. The emergence of SI variants occurred at a median CD4 T mL ( figure 1A) . Coinciding with the first detection of SI variants, a rapid 3-fold increase in median RNA level was cell count of 380 1 10 6 /L (IQR, 250 -590) (figure 1B). Thereafter, an accelerated decline in CD4 cells was observed compared observed to 90,000 copies/mL (IQR, 26,000 -260,000) or 5.0 log copies/mL at 15 months after conversion. Subsequently, with the period before the conversion. Median CD4 cell count at 15 months after the conversion was 200 1 10 6 /L (IQR, 100 -median RNA level declined to a higher equilibrium than before conversion. This equilibrium was reached at 33 410).
In figure 2 , we show the dynamics of median RNA level months after seroconversion at Ç50,000 copies/mL (IQR, 17,750 -272,500) or 4.7 log copies/mL. In the comparison from seroconversion onward for those whose virus remained NSI for ú9 years of follow-up and for those who converted group consisting of persons who did not develop SI virus, median RNA levels were observed of Ç20,000 copies/mL from NSI phenotype to SI phenotype. The group with NSI virus for ú9 years had median RNA levels between 10,000 and (at the 03 months time point, median, 16,000; IQR, õ1000 -33,000). Levels remained at about the same level in the NSI 25,000 copies/mL in the 6 years after HIV-1 seroconversion. Comparable median RNA levels were found for the NSI course group, although fluctuations in median RNA level increased with time because of the small number of measurements at of those who eventually converted in viral phenotype. From the first emergence of SI variants, median RNA levels fluctuated the extreme time points. The difference in RNA level between the group that experienced SI conversion and the NSI group between 55,000 and 112,000 copies/mL in the 6 years after seroconversion, which were higher than RNA levels at the was statistically significant from 9 months before till 33 months after conversion. The median RNA level at 15 months same time point in the other groups. Cumulative incidence of SI switch and predictors for switch. after conversion was significantly higher than the median RNA level at 3 months before conversion (P Å .001).
The cumulative incidence of the NSI-to-SI conversion at 3, 6, and 9 years after seroconversion is 12%, 32%, and 37%, The decline in RNA level from 15 months after phenotype conversion might be caused by exhaustion of infectible CD4 respectively. Subjects with RNA level ú4.9 log (relative hazard [RH], 1.6; 95% confidence interval [CI], 0.8 -3.3, compared T cells. However, no indications were found that very low CD4 T cell counts were associated with low RNA levels (data not with those with RNA õ4.5 log) or CD4 T cell count £500 (RH, 1.9; 95% CI, 0.9 -3.9, compared with those with counts shown), and exclusion of RNA measurements at time points with CD4 T cell counts õ100 revealed a similar pattern of an ú500) were at increased risk for phenotype conversion. However, the RHs were not statistically significant. increase followed by a decrease in RNA after the conversion. Another explanation for the decline from 15 months after the Predictive value for progression to AIDS. In univariate analysis, high RNA level is associated with a faster progression conversion might be the RNA determinations that are missed because of attrition (participants who were lost to follow-up to AIDS (table 1) . Subjects with RNA levels ú4.5 log had a 4-to 7-fold-increased risk for progression to AIDS. Also, viral because of disease progression or death). However, studying participants who were followed for ú3 years after the emerphenotype was a strong predictor for progression to AIDS, with a 5-fold-increased risk for those with NSI-to-SI phenotype gence of SI variants revealed a similar pattern.
The potential impact of antiretroviral treatment was studied conversion compared with those whose virus remained NSI. The strongest univariate predictor was CD4 T cell count; subby excluding RNA measurements from the start of antiretroviral treatment. A similar pattern could still be observed, with jects with õ300 CD4 T cells were 19-fold more likely to develop AIDS than were subjects with higher CD4 T cell even greater differences in RNA level between the group who experienced SI conversion and the NSI group.
counts. In the multivariate analysis, SI phenotype was an inde-/ 9d4c$$au17 06-29-98 13:01:48 jinfas UC: J Infect / 9d4c$$au17 06-29-98 13:01:48 jinfas UC: J Infect Figure 2 . Median RNA levels during time since HIV-1 seroconversion for those whose virus remained non -syncytium-inducing (NSI) for ú9 years after seroconversion (n Å 12) and those with conversion from NSI to syncytium-inducing (SI) phenotype at some time point during follow-up (n Å 39), shown as separate curves for NSI course and SI course.
pendent predictor for progression to AIDS in addition to RNA Discussion level and CD4 T cell count. The RHs of all three predictors
In this large group of HIV-infected homosexual men with decreased, but all remained significantly associated with prodocumented interval of seroconversion, we observed a 3-fold gression to AIDS. No statistical interaction was found between increase in the median serum HIV-1 RNA level coinciding with the markers.
the NSI-to-SI phenotype conversion, which was not observed in matched controls in whom a phenotype conversion did not occur. Since samples from both groups were tested simultane- 1 -5.8) varied between individuals; while in most cases the increase ú4.9 6.6 (3.0 -14.3) 3.0 (1.3 -6.7) seemed to follow the conversion, in others it seemed to precede Phenotype the conversion. However, because of uncertainty related to the tions of an increase in virus could be biologically explained NOTE. NSI, non -syncytium-inducing; SI, syncytium-inducing.
by a broader T cell host range for SI variants [8] , which can / 9d4c$$au17 06-29-98 13:01:48 jinfas UC: J Infect probably be explained from the fact that SI variants can infect rent criteria for antiretroviral treatment based on RNA level (ú10,000 copies/mL) and CD4 T cell count (õ500 1 10 6 /L), CXCR4-expressing T cells in addition to CCR5-expressing cells [14] . A 3-fold increase in RNA level is important with the vast majority of our study population whose viral phenotype converted (37 of the 39) were eligible for treatment before regard to prognosis, as reported by Mellors et al. [15] , who showed a 50% -60% higher risk for progression to AIDS assophenotype conversion. The few patients who experience phenotype conversion and do not meet the criteria for therapy are at ciated with a 3-fold increase in RNA. As antiretroviral treatment is mostly started in subjects with low CD4 T cell counts high risk for disease progression and should be considered for treatment to prevent the associated CD4 T cell decline and/or and high virus loads, it biases the results towards unity. Hence, if treatment were taken into account, the RNA increase might RNA increase.
In conclusion, we found that the NSI-to-SI phenotype coneven be greater.
Following the increase, the RNA level is observed to deversion coincided with an increase in RNA level followed by a decrease to a higher steady-state level than before the switch. crease to a new steady state at a higher RNA level than before the switch. No indications were found that this decline was After adjusting for RNA level and CD4 T cell count, SI phenotype was an independent marker for progression to AIDS. due to exhaustion of infectible CD4 T cells, although no differentiation was made between CXCR4-and CCR5-positive cells, Hence, phenotype determination will contribute to optimal staging of HIV-infected persons in addition to virus load meanor due to missing RNA determinations caused by attrition. The RNA decline might be biologically explained by the humoral or surements and CD4 T cell count. cellular immune response (or both) evoked by the SI variants and/or the increase in virus. Another explanation for the RNA decline might be the depletion of activated target cells due to
